$FTRE News

Mizuho Maintains Neutral on Fortrea Holdings, Raises Price Target to $13

Citigroup Maintains Buy on Fortrea Holdings, Raises Price Target to $20

Barclays Maintains Equal-Weight on Fortrea Holdings, Raises Price Target to $16

Fortrea Holdings Inc. (FTRE) Q1 2026 Earnings Call Transcript

Fortrea (NASDAQ:FTRE) Beats on Q1 Profit but Revenue Miss Caps Gains

Fortrea Holdings Inc. 2026 Q1 - Results - Earnings Call Presentation

Fortrea Holdings Affirms FY2026 Sales Guidance of $2.550B-$2.650B vs $2.594B Est

Fortrea Holdings Q1 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $636.500M Beat $625.397M Estimate

Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?

Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth

Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call

Evercore Adjusts Fortrea Holdings Inc. (FTRE) Valuation Following Updated Near-Term Assumptions

3 Reasons to Avoid FTRE and 1 Stock to Buy Instead

Evercore ISI Group Maintains Outperform on Fortrea Holdings, Lowers Price Target to $14

Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials

Implied Volatility Surging for Fortrea Holdings Stock Options

1 Healthcare Stock to Consider Right Now and 2 We Turn Down

Why Fortrea (FTRE) Stock Is Up Today

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

How The Fortrea (FTRE) Story Is Shifting As Analysts Split On Future Upside